349 filings
Page 3 of 18
8-K
kejs44c hp
21 May 21
Seelos Therapeutics Announces Pricing of $60 Million Public Offering of Common Stock
12:00am
8-K
pb87kct
17 May 21
Regulation FD Disclosure
6:12am
8-K
isxe2xit2jwgu50p
18 Feb 21
Entry into a Material Definitive Agreement
7:05am
8-K
jl8 t2po4l
28 Jan 21
Seelos Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriter's Option to Purchase Additional Shares
10:14am
8-K
eo2xmk3725 qhi
26 Jan 21
Seelos Therapeutics Announces Pricing of $31.25 Million Public Offering of Common Stock
5:09pm
8-K
ra0ej492v2binal
12 Jan 21
Other Events
12:00am
8-K
do3u7l uzbbe3xa
17 Dec 20
Entry into a Material Definitive Agreement
4:05pm
8-K
ln2vz80 3p2yktg
14 Dec 20
Regulation FD Disclosure
9:12am
8-K
tlvvspwektch 4ulzox4
13 Nov 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:16pm
8-K
3ged5o o25zad1q
9 Sep 20
Seelos Therapeutics Announces Closing of $7.0 Million Registered Direct Offering
4:02pm
8-K
4ewmazqo
11 Jun 20
Other Events
9:00am
8-K/A
ib7m6pvkt72y11u4 gf
21 May 20
Material Modifications to Rights of Security Holders
12:00am
8-K
d824j54 6eq
19 May 20
Material Modifications to Rights of Security Holders
8:30am
8-K
jyt3f
15 May 20
Seelos Therapeutics Announces Appointment of Judith Dunn to the Board of Directors
10:31am
8-K
h1m7b3uci3mccfy
24 Apr 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:15pm
8-K
jxxbmdpg
17 Apr 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:15pm
8-K
4ky6aohg ra
30 Mar 20
Departure of Directors or Certain Officers
4:16pm
8-K
oodowf6k
16 Mar 20
Seelos Therapeutics Announces Closing of Public Offering of Common Stock
4:30pm
8-K
yl5gu41 cogzx0onut78
12 Mar 20
Seelos Therapeutics Announces Pricing of $4.5 Million Public Offering of Common Stock
5:24pm
8-K
w850y0iz v1g
13 Feb 20
Seelos Therapeutics Announces Closing of Public Offering of Common Stock
4:30pm